Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
InChi: InChI=1S/C17H8Cl3N3O2/c18-8-1-3-10(13(20)5-8)15(24)12(7-21)16-22-14-6-9(19)2-4-11(14)17(25)23-16/h1-6
Real-time PCR analysis shows that AP20187 (B/B Homodimerizer) (0
4-dichlorophenoxy)methyl]-2-fluoro-N-methanesulfonylbenzamide
SIS3 HCl significantly inhibits L4 development at five concentrations from as low as 2 µM to 50 µM (5 µM
assessment
Palonosetron Hydrochloride llotoxin InChi: InChI=1S/C17H8Cl3N3O2/c18-8-1-3-10(13(20)5-8)15(24)12(7-21)16-22-14-6-9(19)2-4-11(14)17(25)23-16/h1-6Palonosetron (INN, trade name Aloxi) is a 5 HT3 antagonist used in the prevention and treatment of chemotherapy induced nausea and vomiting (CINV). It is used for the control of delayed CINVnausea and vomiting and there are tentative data to suggest that it may be better than granisetron. Palonosetron is administered intravenously, as a single dose, 30 minutes before chemotherapy, or as a single oral capsule one hour before chemotherapy. The oral
US$ 18.50
US$ 10.99
US$ 110.00